Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of fourteen rule-out strategies for acute myocardial infarction.

International journal of cardiology·2018
Same author

Daytime variation of perioperative myocardial injury in non-cardiac surgery and effect on outcome.

Heart (British Cardiac Society)·2018
Same author

Variations on classification of main types of myocardial infarction: a systematic review and outcome meta-analysis.

Clinical research in cardiology : official journal of the German Cardiac Society·2018
Same author

Rhabdomyolysis: A Noncardiac Source of Increased Circulating Concentrations of Cardiac Troponin T?

Journal of the American College of Cardiology·2018
Same author

Reply: Hospital Charges Associated With Inpatient Troponin Testing.

Journal of the American College of Cardiology·2018
Same author

Inflammatory Biomarkers and Clinical Judgment in the Emergency Diagnosis of Urgent Abdominal Pain.

Clinical chemistry·2018
Same journal

Nanotechnology-Stem Cell Strategies in 3D Glioblastoma Organoid: Targeting Glioma Stem Cells Within a Complex Tumor Microenvironment.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Mapping the 3D Chromosome Organization of a Biosynthetic Gene Cluster by Capture Hi-C (CHi-C).

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Mapping the 3D Chromosome Organization of Streptomyces by Hi-C.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

CUT&Tag Epigenomic Profiling of Biosynthetic Gene Clusters in Arabidopsis thaliana.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Rhizobium rhizogenes-Mediated Hairy Root Transformation Protocol for Lotus japonicus and Other Legumes.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Characterization of Bioactive Saponins from Sea Cucumbers.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

Related Experiment Video

Updated: May 28, 2026

Using Adeno-associated Virus as a Tool to Study Retinal Barriers in Disease
10:14

Using Adeno-associated Virus as a Tool to Study Retinal Barriers in Disease

Published on: April 19, 2015

Preclinical study design for rAAV.

Terence R Flotte1, Thomas J Conlon, Christian Mueller

  • 1Department of Pediatrics, University of Massachusetts Medical School Gene Therapy Center, Worcester, MA, USA. terry.flotte@umassmed.edu

Methods in Molecular Biology (Clifton, N.J.)
|October 29, 2011
PubMed
Summary
This summary is machine-generated.

Developing novel drugs like adeno-associated viral vectors for human trials requires extensive preclinical toxicology and biodistribution studies. This process ensures a robust safety profile through careful study design and regulatory compliance.

More Related Videos

Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector
08:33

Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector

Published on: February 28, 2016

A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning
09:22

A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning

Published on: June 22, 2015

Related Experiment Videos

Last Updated: May 28, 2026

Using Adeno-associated Virus as a Tool to Study Retinal Barriers in Disease
10:14

Using Adeno-associated Virus as a Tool to Study Retinal Barriers in Disease

Published on: April 19, 2015

Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector
08:33

Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector

Published on: February 28, 2016

A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning
09:22

A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning

Published on: June 22, 2015

Area of Science:

  • Biotechnology
  • Pharmacology
  • Toxicology

Background:

  • Translating novel therapeutics, such as adeno-associated viral vectors, from research to clinical application is a complex, multi-year endeavor.
  • Regulatory agencies and research teams collaborate extensively to ensure drug safety before human trials.
  • Preclinical studies are critical for establishing a comprehensive safety profile.

Purpose of the Study:

  • To outline key considerations in designing and conducting preclinical pharmacology-toxicology (pharm-tox) studies for novel drugs.
  • To detail essential components of the drug development pathway towards Phase I clinical trials.
  • To emphasize the importance of regulatory compliance and quality assurance in drug safety evaluation.

Main Methods:

  • Discussion of critical elements in pharm-tox study design, including animal model selection (species and number) and dose determination.
  • Overview of standard toxicological assays integral to safety profiling.
  • Emphasis on adherence to Standard Operating Procedures (SOPs) and Good Laboratory Practices (GLP).

Main Results:

  • The abstract does not contain specific results but outlines the methodologies and considerations for preclinical drug safety studies.
  • Highlights the necessity of a structured approach to toxicology and biodistribution studies.
  • Underscores the role of the Quality Assurance Unit in ensuring study integrity.

Conclusions:

  • Successful progression of novel drugs to human trials hinges on rigorous preclinical safety assessments.
  • Adherence to regulatory guidelines and robust study design are paramount for drug development.
  • Comprehensive toxicology and biodistribution studies are essential for establishing the safety profile of new therapeutic agents.